Dolby Laboratories Lowers FY2026 Adj EPS Guidance from $4.30-$4.45 to $4.25-$4.40 vs $4.30 Est; Narrows FY2026 Sales Guidance from $1.400B-$
Dolby Laboratories (NYSE: DLB ) lowers FY2026 Adj EPS guidance from $4.30-$4.45 to $4.25-$4.40 vs $4.30 analyst estimate. Narrows FY2026 sales outlook from $1.400 billion-$1.450 billion to $1.410 billion-$1.440 billion vs $1.407 billion estimate.
Story updates
08:33:18 PM UTC
SquawkNews
Dolby Laboratories (NYSE: DLB ) lowers FY2026 GAAP EPS guidance from $2.66-$2.81 to $2.62-$2.77 vs $2.83 analyst estimate..
Dolby Laboratories (NYSE: DLB ) lowers FY2026 Adj EPS guidance from $4.30-$4.45 to $4.25-$4.40 vs $4.30 analyst estimate.
Narrows FY2026 sales outlook from $1.400 billion-$1.450 billion to $1.410 billion-$1.440 billion vs $1.407 billion estimate.